{
    "Title": "Efficacy and safety of a combined treatment of sodium stibogluconate at 20mg/kg/day with upper maximum daily dose limit of 850mg and Paromomycin 15mg/kg/day in HIV negative visceral leishmaniasis patients. A retrospective study, northwest Ethiopia",
    "URL": "https://doi.org/10.1371/journal.pntd.0009713",
    "Published": "August 31, 2021",
    "Subject_Areas": [
        "Leishmaniasis",
        "HIV",
        "Adverse events",
        "Toxicity",
        "Ethiopia",
        "Pancreatitis",
        "Sepsis",
        "Pneumonia"
    ],
    "Authors": {
        "Aschalew Tamiru": [
            "Leishmaniasis Research and Treatment Center, University of Gondar, College of Medicine and Health Science, Gondar, Ethiopia"
        ],
        "Rezika Mohammed": [
            "Department of Internal Medicine, University of Gondar, College of Medicine and Health Sciences, Gondar, Ethiopia"
        ],
        "Saba Atnafu": [
            "Leishmaniasis Research and Treatment Center, University of Gondar, College of Medicine and Health Science, Gondar, Ethiopia"
        ],
        "Girmay Medhin": [
            "Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia"
        ],
        "Asrat Hailu": [
            "Department of Microbiology, Immunology and Parasitology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia"
        ]
    }
}